Genenta Science S.p.A. Research and Development Expense
Genenta Science S.p.A. (GNTA) reported Research and Development Expense of EUR 2.70 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-04-01
| Period end | Research and Development Expense | Research and Development Expense 6 month | Research and Development Expense 12 month |
|---|---|---|---|
| 2025-12-31 | 2.70M EUR 20-F · filed 2026-04-01 | ||
| 2025-06-30 | 1.45M EUR 6-K · filed 2025-10-10 | ||
| 2024-12-31 | 4.81M EUR 20-F · filed 2026-04-01 | ||
| 2024-06-30 | 2.04M EUR 6-K · filed 2025-10-10 | ||
| 2023-12-31 | 6.47M EUR 20-F · filed 2026-04-01 | ||
| 2023-06-30 | 3.92M EUR 6-K · filed 2024-10-29 | ||
| 2022-12-31 | 5.34M EUR 20-F · filed 2025-03-28 | ||
| 2022-06-30 | 1.64M EUR 6-K · filed 2023-10-20 | ||
| 2022-04-27 | 158.00K EUR 20-F · filed 2023-04-21 | ||
| 2021-12-31 | 3.39M EUR 20-F · filed 2024-03-29 | ||
| 2021-06-30 | 3.20M EUR 6-K · filed 2022-10-25 | ||
| 2020-12-31 | 4.69M EUR 20-F · filed 2023-04-21 | ||
| 2019-12-31 | 3.70M EUR 20-F · filed 2022-05-02 |